PPARG and breast cancer: In another study [17], α-ESA, considered as a PPARγ agonist like rosiglitazone, as well as GLA [38], suppressed cell growth in BC cell lines by activating PPARγ nuclear compartmentalization, which suggested that nuclear localization of PPARγ plays a role in anti-cancer functions in BC.